TAT and lymphoma: Additionally, HIV-1 Tat enhances c-MYC transcription by binding to the c-MYC promoter, which can contribute to a more aggressive lymphoma phenotype (Lazzi et al., 2002; Alves de Souza Rios et al., 2021).